Expert Review of Anti-Infective Therapy

Article	Citations
An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies	182
Antimicrobial resistance in low- and middle-income countries: current status and future directions	118
Calycosin: a Review of its Pharmacological Effects and Application Prospects	74
Current and emerging strategies to combat antimalarial resistance	64
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae	55
CAR-T cell therapy and infection: a review	53
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis	51
Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management	50
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials	49
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal	44
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications	42
Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities	39
Bacterial death from treatment with fluoroquinolones and other lethal stressors	37
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies	37
Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2	35
Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations	33
Addressing antimicrobial resistance in Nigerian hospitals: exploring physicians prescribing behavior, knowledge, and perception of antimicrobial resistance and stewardship programs	33
A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications	33
Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy	31
Bacteria and fungi as major bio-sources to fabricate silver nanoparticles with antibacterial activities	31
Dengue vaccine: an update	30
A review on favipiravir: the properties, function, and usefulness to treat COVID-19	30
Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies	28
RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study	28
Therapeutic strategies to address monkeypox	27

Antibiotic consumption among hospitalized neonates and children in Punjab province, Pakistan	27
Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis	27
Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria	26
Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints	26
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV	26
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams	25
Quorum sensing: a new prospect for the management of antimicrobial-resistant infectious diseases	24
The war against bacteria, from the past to present and beyond	23
Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs	23
Treatment of carbapenem-resistantPseudomonas aeruginosainfections: a case for cefiderocol	22
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections	22
Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress	21
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition	20
Impact of bacterial infections on erythropoiesis	20
Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis	20
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance	20
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects	20
Intravenous fosfomycin for the treatment of patients with bone and joint infections: a review	19
A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications	18
Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads	18
Adolescents and young adults with early acquired HIV infection in the united states: unique challenges in treatment and secondary prevention	18
Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease	18
Implementation of antimicrobial stewardship to reduce antimicrobial drug resistance	18
Risk of infection in patients with hematological malignancies receiving CAR T-cell therapy: systematic review and meta-analysis	18
SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis	17
Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?	17
Fostemsavir for the treatment of HIV	17
Anti-inflammatory effects of GLP-1 in patients with COVID-19	17
Healthcare-associated ventriculitis: current and emerging diagnostic and treatment strategies	16
Adjuvant use of combination of antibiotics in acute severe ulcerative colitis: A placebo controlled randomized trial	16
Diagnosis, prevention, and treatment of coronavirus disease: a review	15
Drug repurposing: new strategies for addressing COVID-19 outbreak	15
Bacteriophages for ESKAPE: role in pathogenicity and measures of control	15
The rise of mucormycosis in Covid-19 patients in India	15
Inflammation in neurocysticercosis: clinical relevance and impact on treatment decisions	15
Predictors of mortality in invasive pneumococcal disease: a meta-analysis	15
Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatment	14
Evaluation of favipiravir in the treatment of COVID-19 based on the real-world	14
Managing sepsis in the era of precision medicine: challenges and opportunities	14
Recent innovations and new applications of outpatient parenteral antimicrobial therapy	14
Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice	14
Molecular diagnosis of toxoplasmosis: recent advances and a look to the future	14
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy	14
COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention	13
Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review	13
Spontaneous loss of chronic HBV infection markers in treatment-naïve children: a systematic review and pooled meta-analyses	12
Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: an observational prospective open label user survey	12
Clinical impact of procalcitonin-based algorithms for duration of antibiotic treatment in critically ill adult patients with sepsis: a meta-analysis of randomized clinical trials	12
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria	12
An update on endotoxin neutralization strategies in Gram-negative bacterial infections	12

Potential utility of nano-based treatment approaches to address the risk ofHelicobacter pylori	12
Reemergence of monkeypox: prevention and management	12
Application of platelet-rich plasma in traumatic bone infections	11
Sepsis in the critically ill patient: current and emerging management strategies	11
Practical diagnostic algorithms for Chagas disease: a focus on low resource settings	11
The antifungal pipeline for invasive fungal diseases: what does the future hold?	11
The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review	11
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives	11
Lifestyle and rehabilitation during the COVID-19 pandemic: guidance for health professionals and support for exercise and rehabilitation programs	11
Lactic acid bacteria: prominent player in the fight against human pathogens	11
Potential effectiveness and adverse implications of repurposing doxycycline in COVID-19 treatment	11
Bacterial resistance to antibiotics: access, excess, and awareness in Bangladesh	11
Self-medication Behavior with antibiotics: a national cross-sectional survey in Sri Lanka	11
Impact of HIV infection on aging and immune status	11
Scrub typhus and antibiotic-resistant Orientia tsutsugamushi	11
Exacerbation of antimicrobial resistance: another casualty of the COVID-19 pandemic?	11
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision	11
Current updates in diagnosis of male urogenital tuberculosis	10
Classification for β-lactamases: historical perspectives	10
The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies	10
Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring	10
Comparison of tailored Helicobacter pylori eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial	10
Lack of antibiotic knowledge and misuse of antibiotics by medical students in Mali: a cross-sectional study	10
Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries	10
Prevalence and determinants of self-medication with antibiotics among general population in Afghanistan	10
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)	10
Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19	10
Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box	10
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas	10
Clostridioides difficile infection: an emerging zoonosis?	9
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge	9
Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin	9
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development	9
Escalation of antimicrobial resistance among MRSA part 1: focus on global spread	9
Outpatient treatment options to address the SARS-CoV-2 variant Omicron	9
Visceral leishmaniasis elimination in India: progress and the road ahead	9
Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases	9
Antibiotic use among hospitalized children with lower respiratory tract infections: a multicenter, retrospective study from Punjab, Pakistan	9
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review	9
Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures	9
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae	9
The antifungal activity of caspofungin in combination with antifungals or non-antifungals against Candida species in vitro and in clinical therapy	9
Secnidazole: a treatment for trichomoniasis in adolescents and adults	8
Possible effects of Porphyromonas gingivalis on the blood–brain barrier in Alzheimer’s disease	8
Mycosynthesis of AgNPs: mechanisms of nanoparticle formation and antimicrobial activities	8
Recent progress in the repurposing of drugs/molecules for the management of COVID-19	8
The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	8
Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection	8
Brain-eating amoebae: is killing the parasite our only option to prevent death?	8
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis	8
Clinical characteristics and outcomes in adult patients hospitalized with influenza, respiratory syncytial virus and human metapneumovirus infections	8
Containment strategies for COVID-19 in India: lessons from the second wave	8
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials	8
Effects of supplementation with low-dose group B vitamins on clinical and biochemical parameters in critically ill patients with COVID-19: a randomized clinical trial	8
Neonatal ocular prophylaxis in the United States: is it still necessary?	8
Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options	7
Diagnostic stewardship based on patient profiles: differential approaches in acute versus chronic infectious syndromes	7
Efficacy and acceptability of different anti-fungal interventions in oropharyngeal or esophageal candidiasis in HIV co-infected adults: a pilot network meta-analysis	7
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	7
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critical	7
Prevalence of antibiotic self-medication behavior and related factors among children aged 0 to 5 years	7
Clinical efficacy and safety of interferon-β–containing regimens in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	7
Omadacycline in treating community-based infections: a review and expert perspective	7
The value of infectious disease modeling and trend assessment: a public health perspective	7
Genetic heterogeneity of group A rotaviruses: a review of the evolutionary dynamics and implication on vaccination	7
Delafloxacin for the treatment of adult patients with community-acquired bacterial pneumonia	7
Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis	7
Strengths and caveats of identifying resistance genes from whole genome sequencing data	7
Clinical efficacy and safety of ceftobiprole in the treatment of acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials	7
A profile of the live biotherapeutic product RBX2660 and its role in preventing recurrent Clostridioides difficile infection	7
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits	7
Impact of tuberculosis disease on human gut microbiota: a systematic review	7
Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study	7
Role of the inflammatory response in community-acquired pneumonia: clinical implications	6
False-positivity results in rapid antigen tests for SARS-CoV-2: an umbrella review of meta-analyses and systematic reviews	6
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective	6
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)	6
Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)	6
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin	6
New advances in the treatments of drug-resistant tuberculosis	6

Therapeutic drug monitoring (TDM) in real-time: a need for the present future	6
Antimicrobial prescribing for treatment of serious infections caused by Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in pediatrics: an expert review	6
Antibacterial activity of essential oils for combating colistin-resistant bacteria	6
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects	6
Associations of infection control measures and norovirus outbreak outcomes in healthcare settings: a systematic review and meta-analysis	6
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach	6
Prevalence of antimicrobial use in a tertiary academic hospital: a venue for antimicrobial stewardship programs	6
Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age	6
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	6
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury	6
Multidrug-resistantAcinetobacter baumanniiinfections: looming threat in the Indian clinical setting	6
Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials	6
Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU	6
Statin use and impact on tuberculosis risk	6
Epidemiology and microbiology of Gram-negative bloodstream infections in a tertiary-care hospital in Beijing, China: a 9-year retrospective study	6
Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates	6
How effective are rapid diagnostic tests for Chagas disease?	6
Molecular detections of coronavirus: current and emerging methodologies	5
Concerns with current Drug Laws regarding the purchasing antibiotics without a prescription in Pakistan; ways forward to assist the national action plan	5
Antimicrobial pharmacokinetics and preclinicalin vitromodels to support optimized treatment approaches for uncomplicated lower urinary tract infections	5
Infliximab as a potential treatment for COVID-19	5
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin	5
Novel strategies to diagnose prosthetic or native bone and joint infections	5
Understanding Staphylococcus aureus internalisation and induction of antimicrobial tolerance	5
Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review	5
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review	5
Antimicrobial resistance inVibrio choleraeO1/O139 clinical isolates: a systematic review and meta-analysis	5
Comparative effectiveness of pharmacological interventions on mortality and the average length of hospital stay of patients with COVID-19: a systematic review and meta-analysis of randomized controlle	5
One-stage revision surgery provides infection eradication and satisfying outcomes for infected knee arthroplasty in selected patients	5
Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis	5
Will invasive fungal infections be The Last of Us? The importance of surveillance, public-health interventions, and antifungal stewardship	5
Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies	5
Candida auris biofilm: a review on model to mechanism conservation	5
How can we tackle the overuse of antibiotics in low- and middle-income countries?	5
The contributions of multidrug resistant clones to the success of pandemic extra-intestinal Pathogenic Escherichia coli	5
Brucellosis control methods with an emphasis on vaccination: a systematic review	5
Elbasvir and grazoprevir for the treatment of hepatitis C	5
Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios	5
Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients	5
Treating urinary tract infections in the era of antibiotic resistance	5
Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China	5
New insights into the treatment of acute otitis media	5
New perspectives in the antibiotic treatment of mechanically ventilated patients with infections from Gram-negatives	5
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana	4
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review	4
A systems thinking approach for antimicrobial stewardship in primary care	4
Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development po	4
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19	4
Phage therapy in pediatrics: the way forward for difficult-to-treat infections?	4
Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae	4
Updates in the management of respiratory virus infections in ICU patients: revisiting the non-SARS-CoV-2 pathogens	4
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	4
Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis	4
Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review	4
Potential role of glycoprotein 340 in milder SARS-CoV-2 infection in children	4
Prevention and treatment of burn wound infections: the role of topical antimicrobials	4
Infection-related stillbirth: an update on current knowledge and strategies for prevention	4
Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies	4
Hyperimmunoglobulin therapy for the prevention and treatment of congenital cytomegalovirus: a systematic review and meta-analysis	4
Comparing prolonged infusion to intermittent infusion strategies for beta-lactam antibiotics in patients with gram-negative bacterial infections: a systematic review and meta-analysis	4
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose	4
An update on the myriad antifungal resistance mechanisms in dermatophytes and the place of experimental and existential therapeutic agents for Trichophyton complex implicated in tinea corporis	4
Comparing intravenous peramivir with oral oseltamivir for patients with influenza: a meta-analysis of randomized controlled trials	4
Novel treatment dynamics for biofilm-related infections	4
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials	4
Reviewing novel treatment options for carbapenem-resistant Enterobacterales	4
Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy	4
Strategies to improve the diagnosis and clinical treatment of dermatophyte infections	4
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials	3
Old biomarkers in tuberculosis management: are they still useful? a systematic review	3
Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal againstHelicobacter pylori	3
Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now	3
The impact of COVID-19 on the HIV continuum of care: challenges, innovations, and opportunities	3
Anti-MRSA quinolones for acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials	3
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review	3
Langya henipavirus outbreak	3
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better	3
Understanding the genetic basis of immune responses to fungal infection	3
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses	3
Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV)	3
The association between neutrophil to lymphocyte ratio and endothelial dysfunction in people living with HIV on stable antiretroviral therapy	3
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies	3
Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment	3
The circadian rhythm of viruses and its implications on susceptibility to infection	3
Staphylococcus aureus antimicrobial susceptibility trends and cluster detection in Vermont: 2012-2018	3
Clostridioides difficile infection in inflammatory bowel disease: a clinical review	3
Recurrent bloodstream infections after allogeneic hematopoietic cell transplantation	3
Host-directed therapies for malaria and tuberculosis: common infection strategies and repurposed drugs	3
Diagnostic and management strategies for chronic hepatitis E infection	3
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan	3
COVID-19 and inhibitors of the renin–angiotensin–aldosterone system	3
The gene profile of Enterobacteriaceae virulence factors in relation to bacteriuria levels between the acute episodes of recurrent uncomplicated lower urinary tract infection	3
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	3
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship	3
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status	3